RSS   Newsletter   Contact   Advertise with us

Bayer to acquire Asklepios BioPharmaceutical for as much as $4 billion

Christian Fernsby ▼ | October 26, 2020
Bayer agreed to acquire Asklepios BioPharmaceutical Inc. for as much as $4 billion.
Asklepios BioPharmaceutical   Bayer
Bayer will pay $2 billion upfront and potential milestone payments of $2 billion for closely held AskBio, a North Carolina based company that’s developing gene therapies for diseases including Parkinson’s and congestive heart failure, according to a joint statement.

Topics: Bayer

Bayer expects the deal to close later this year, and AskBio will continue to operate as an independent company, the companies said.